Logo image
Initiation of cardiac hypertrophy in response to thyroxine is not limited by age
Journal article   Peer reviewed

Initiation of cardiac hypertrophy in response to thyroxine is not limited by age

Robert J Tomanek, Carol A Butters and M Bridget Zimmerman
The American journal of physiology, Vol.264(4 Pt 2), pp.H1041-H1047
04/1993
DOI: 10.1152/ajpheart.1993.264.4.H1041
PMID: 8476081

View Online

Abstract

We examined the role of age in the initiation of thyroxine-induced (T4) cardiac hypertrophy. T4 (0.4 mg/kg sc) was administered to prepubescent (2 mo), young adult (6 mo), and senescent (24 mo) Fischer 344 rats for 4 days. While significant increases in left ventricular (LV) mass and RNA/LV were evident at 4 days in all T4-treated groups, the elevation in RNA/LV occurred earlier (2 days) in the senescent group. A 0.2-mg/kg dose of T4 elevated RNA values within 24 h in senescent, but not in prepubescent, rats. LV norepinephrine levels were measured to determine whether it plays a role in this model of cardiac hypertrophy. When synthesis of this catecholamine was blocked with alpha-methyl-p-tyrosine, tissue levels fell significantly in all groups, and the decrement was similar in T4-treated and control rats in the two younger groups. We conclude that: 1) the initiation of T4-induced cardiac hypertrophy is not compromised in senescent rats, 2) hearts of senescent rats respond earlier and to a lower dose of T4 than young rats, and 3) the cardiac hypertrophy that occurs in hyperthyroidism is not due to enhanced levels of available cardiac norepinephrine.
Myocardium - chemistry Norepinephrine - physiology Heart - physiology Rats, Inbred F344 Rats Male Myocardium - pathology Norepinephrine - analysis Hemodynamics - physiology Dose-Response Relationship, Drug Thyroxine - adverse effects Hypertrophy, Left Ventricular - chemically induced Animals Aging - physiology DNA - analysis Hypertrophy, Left Ventricular - physiopathology Disease Models, Animal

Details

Metrics

Logo image